Abivax (AAVXF) Net Income (2022 - 2026)

Abivax has reported Net Income for 5 years, with the latest figure at $56.7 million in Q1 2026.

• On a quarterly basis, Net Income rose 3.01% year-over-year to $56.7 million in Q1 2026; TTM through Mar 2026 was $391.2 billion, a 107.72% increase from a year earlier, with the FY2025 full-year figure at $391.2 billion, up 107.74% from the prior year.
• Net Income was $56.7 million for Q1 2026 at Abivax, down from $390.9 billion in the prior quarter.
• The five-year high for Net Income was $390.9 billion in Q4 2025, with the low at -$137.1 million in Q4 2023.
• Average Net Income over 5 years is $52.7 billion, with a median of $55.1 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Net Income sank 107.34% in 2023, then surged 137386.51% in 2024.
• Over 5 years, Net Income stood at -$66.1 million in 2022, then plunged by 107.34% to -$137.1 million in 2023, then soared by 137386.51% to $188.2 billion in 2024, then jumped by 107.74% to $390.9 billion in 2025, then tumbled by 99.99% to $56.7 million in 2026.
• The last three Net Income figures came in at $56.7 million (Q1 2026), $390.9 billion (Q4 2025), and $179.3 million (Q3 2025), per Business Quant data.